↓ Skip to main content

Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completion

Overview of attention for article published in Cardiovascular Diabetology, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

twitter
21 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completion
Published in
Cardiovascular Diabetology, October 2019
DOI 10.1186/s12933-019-0938-6
Authors

Milton Packer

Twitter Demographics

The data shown below were collected from the profiles of 21 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Other 12 21%
Student > Ph. D. Student 9 16%
Researcher 7 13%
Student > Master 4 7%
Student > Postgraduate 4 7%
Other 10 18%
Unknown 10 18%
Readers by discipline Count As %
Medicine and Dentistry 32 57%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Arts and Humanities 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Business, Management and Accounting 1 2%
Other 4 7%
Unknown 12 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2020.
All research outputs
#1,552,792
of 15,184,210 outputs
Outputs from Cardiovascular Diabetology
#81
of 863 outputs
Outputs of similar age
#42,631
of 268,482 outputs
Outputs of similar age from Cardiovascular Diabetology
#1
of 1 outputs
Altmetric has tracked 15,184,210 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 863 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,482 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them